LAVOLTIDINE

Details

Stereochemistry	ACHIRAL
Molecular Formula	C19H29N5O2
Molecular Weight	359.4659
Optical Activity	NONE
Defined Stereocenters	0 / 0
E/Z Centers	0
Charge	0

SHOW SMILES / InChI

Structure Search

SMILES

CN1N=C(CO)N=C1NCCCOC2=CC=CC(CN3CCCCC3)=C2

InChI

InChIKey=VTLNPNNUIJHJQB-UHFFFAOYSA-N

InChI=1S/C19H29N5O2/c1-23-19(21-18(15-25)22-23)20-9-6-12-26-17-8-5-7-16(13-17)14-24-10-3-2-4-11-24/h5,7-8,13,25H,2-4,6,9-12,14-15H2,1H3,(H,20,21,22)

HIDE SMILES / InChI

Molecular Formula	C19H29N5O2
Molecular Weight	359.4659
Charge	0
Count

Stereochemistry	ACHIRAL
Additional Stereochemistry	No
Defined Stereocenters	0 / 0
E/Z Centers	0
Optical Activity	NONE

Description
Sources: https://www.ncbi.nlm.nih.gov/pubmed/6145595 | https://www.ncbi.nlm.nih.gov/pubmed/4041682 | https://www.ncbi.nlm.nih.gov/pubmed/2878860

LAVOLTIDINE, also known as loxtidine, is a highly potent and selective histamine H2-receptor antagonist. It is a member of triazoles. It produces gastric carcinoid tumors in rodents that is why its clinical development was discontinued.

Originator

Approval Year

PubMed

Title	Date	PubMed
Gastrin-induced apoptosis contributes to carcinogenesis in the stomach.	2006 Oct	16894354

Substance Class	Chemical Created by `admin` on `Fri Dec 15 17:20:10 GMT 2023` Edited by `admin` on `Fri Dec 15 17:20:10 GMT 2023`
Record UNII	X16K5179V5
Record Status	`Validated (UNII)`
Record Version

Download

Name

Type

Language

LAVOLTIDINE

Official Name

English

LOXTIDINE

Common Name

English

1H-1,2,4-TRIAZOLE-3-METHANOL, 1-METHYL-5-((3-(3-(1-PIPERIDINYLMETHYL)PHENOXY)PROPYL)AMINO)-

Systematic Name

English

Lavoltidine [WHO-DD]

Common Name

English

AH-23844 FREE BASE

Code

English

lavoltidine [INN]

Common Name

English

1-METHYL-5-((3-((.ALPHA.-PIPERIDINO-M-TOLYL)OXY)PROPYL)AMINO)-1H-1,2,4-TRIAZOLE-3-METHANOL

Systematic Name

English

LOXOTIDINE

Common Name

English

Code System Code Type Description

EPA CompTox

DTXSID0020785